drugset / Trial / NCT06651567
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with agitation associated with Alzheimer's dementia
Timeline
- Start
- 2024-10-22
- Primary completion
- 2027-12-28
- Completion
- 2027-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ITI-1284 | Unknown | 10 mg | Other |
| Subject | ITI-1284 | Unknown | 20 mg | Other |
Indications
No indication recorded.